Trump’s Doctors Hold Press Conference To Give A Brief On President's COVID-19 Fight

President Donald Trump is in high spirits despite being infected with the COVID-19 said his doctors in a press conference held at the Walter Reed National Military Medical Center.

The briefing was led by Navy Commander Dr. Sean Conley to give an update on President Trump's condition since he was transferred to the military hospital from the White House on Friday, October 1, as a precaution.

In the press conference, Dr. Conley, with the rest of Trump's team of doctors behind him, said that the president started exhibiting symptoms of the COVID-19 on Thursday afternoon, October 1.

Dr. Conley added that the president was not put on oxygen on Thursday, not at the moment that the briefing was ongoing nor when he got to the hospital.

According to Dr. Conley, Trump's symptoms included cough and nasal congestion from which he is improving from.

He also said that the president has not had fever for 24 hours already.

Another doctor, Dr. Sean Dooley, said that the president is in exceptionally good spirits despite his COVID-19 infection.

Trump's age, that is 74 years old, his sex and his being clinically obese puts him at a higher risk group said to suffer severe illness as a result of the viral infection.

The United States has the highest number of COVID-19 infections worldwide at more than 7 million and also has the highest number of deaths at more than 200,000.

Mark Meadows, the White House chief of staff, said on Saturday though that President Trump had a very concerning Friday and that his care for the next 48 hours will be critical as he battles the COVID-19 infection.

Meadows said that they are still not on a clear path to a full recovery.

Before the president left for Walter Reed National Military Medical Center, he was given a single dose of an experimental antibody drug to boost his immune system and decrease his risk of developing severe illness.

The drug produced by biotechnology company Regeneron Pharmaceuticals Inc., is said to have the most promising approach in preventing severe illnesses from a COVID-19 infection.

The drug, however, has yet to be approved by the U.S. Food and Drug Administration as it is still in the late-stage testing, and its safety and effectiveness are not yet known.

At the military hospital, Trump was started on a five-day course of the antiviral medication Remdesivir that is said to speed up recovery from a COVID-19 infection.

The antibody drug works on boosting the president's immune system while the Remdesivir will work on stopping the SARS-CoV-2, which causes the COVID-19, from multiplying.

Dr. Conley said that they are maximizing all aspects of President Trump's care by attacking the virus in multiple ways. He added that he does not want to hold back anything if it means adding value to the president's care.

Check these out:

Trump Given Experimental Antibody Drug to Prevent Serious Illness From COVID-19 Infection

Trump to Stay at Walter Reed for a Few Days Following COVID-19 Diagnosis

Black, Latino Residents Often Cited by California Police for Non-Traffic Infractions, Study Says